Cannabidiol (CBD)

CBD products have been becoming popular in recent years. Some merchants claim that CBD products can bring health benefits such as soothing pain and improving sleep quality. However, these claims are not authoritatively proven by science. CBD comes from cannabis plants. Cannabis has tetrahydrocannabinol (THC), which is a strictly controlled dangerous drug and can lead to hallucinations, addiction, depression, etc., and even psychosis. Experts say it is difficult to isolate pure CBD from cannabis. Most likely, CBD products contain trace amounts of THC, which can be harmful. In addition, CBD can naturally decompose into THC under normal storage conditions, and it can be used to produce THC.
From 1 February, 2023, CBD has been listed as a dangerous drug under the Dangerous Drugs Ordinance (DDO). Under the DDO, trafficking (including importing and exporting) and sales of substances in contravention of the law will be subject to a maximum penalty of life imprisonment and a fine of $5 million. Possession and consumption of substances in contravention of the DDO will be subject to a maximum penalty of seven years’ imprisonment and a fine of $1 million.

Reference

Examples of CBD Products

Stay away from drugs when celebrating festive season locally or outside Hong Kong

15.12.2023

First case of incoming passenger imprisoned for being in possession of cannabidiol (CBD) (with photos)

7.7.2023

Community comes together to fight against drugs on World Drug Day (with photos/video)

26.6.2023

Statistical figures of drug abuse and drug situation in Hong Kong in first quarter of 2023

15.6.2023

Drug abuse and drug situation in Hong Kong in 2022 (with photos)

27.3.2023

Stay away from drugs when participating in social and leisure activities

6.3.2023

Opening remarks by S for S at media session after Fight Crime Committee meeting (Chinese only) (with video)

24.2.2023

Hong Kong Customs seizes suspected cannabidiol (CBD) oil and cannabis buds (with photo)

8.2.2023

Control of cannabidiol (CBD) will come into effect tomorrow and violation is a criminal offence

31.1.2023

Hong Kong Customs takes strict enforcement action to control cannabidiol (CBD) from February 1 (with photo)

27.1.2023

LCQ13: Curbing youth committing offences

18.1.2023

Government reminds public to properly handle cannabidiol (CBD) products before February 1

17.1.2023

Stay away from drugs even when you travel (with photo)

19.12.2022

Drug abuse and drug situation in Hong Kong in first three quarters of 2022

16.12.2022

Opening remarks by S for S at media session after Fight Crime Committee meeting (Chinese only) (with video)

12.12.2022

Members of public can visit revamped Hong Kong Jockey Club Drug InfoCentre free of charge (with photo)

5.12.2022

Speech by S for S at reopening ceremony of Hong Kong Jockey Club Drug InfoCentre (Chinese only) (with photos)

28.11.2022

Hong Kong Jockey Club Drug InfoCentre will reopen on December 5 (with photos)

28.11.2022

Speech by S for S at “Motion of Thanks to the Chief Executive” in respect of 2022 Policy Address (Part I) (Chinese only)

16.11.2022

LCQ1: Curbing youth committing drug-related offences

16.11.2022

Security Bureau expresses deep regret over a misleading commentary in Ming Pao on the legislative control of cannabidiol and anti-drug work

3.11.2022

ACAN Chairman supports Government's proposal to control cannabidiol

3.11.2022

ACAN appeals to operators of social media and websites

27.10.2022

Orders to amend Dangerous Drugs Ordinance and Control of Chemicals Ordinance to be gazetted on October 21 and cannabidiol to become dangerous drug

20.10.2022

ACAN welcomes "The Chief Executive's 2022 Policy Address"

19.10.2022

Speech by CE at large-scale anti-drug publicity programme (Chinese only) (with video)

17.9.2022

"Let's Stand Firm. Knock Drugs Out!": Brand-new anti-drug publicity and anti-drug ambassadors announced (with photos/video)

17.9.2022

Online briefing session on controlling CBD by legislation held today

27.6.2022

ACAN notes drug abuse and drug situation in Hong Kong in first quarter of 2022 and supports further control of CBD through legislation

22.6.2022

LCQ20: Regulation of products containing cannabidiol